Literature DB >> 3275755

Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment.

E C Alvord1, S Lofton.   

Abstract

A review of the literature revealed 623 cases of optic gliomas with sufficient information to permit actuarial (life-table) analysis concerning the prognosis of this disease by the patients' age, tumor site, treatment, and presence of concomitant neurofibromatosis or extension into the hypothalamus or ventricle. All of these factors are important. The development of mathematical models led to the conclusion that these tumors, generally regarded histologically as low-grade astrocytomas, actually have a very wide but continuous range of growth rates. Some grow rapidly enough to be explained by simple exponential doubling at a constant rate, but most behave as though their growth decelerates. Decelerating growth rates make comparisons of various groups of patients difficult. No support is found for the classical hypothesis that some may be hamartomas. Inadequately treated gliomas of the optic nerve or chiasm bear about the same poor prognosis. However, tumors of the optic nerve (intracranial as well as intraorbital) have an excellent prognosis following complete surgical excision and only a slightly poorer prognosis following irradiation. About 5% of optic nerve gliomas recur in the chiasm following "complete" intraorbital excision. Patients with neurofibromatosis have about twice the recurrence rate following complete excision of an intraorbital glioma. Optic chiasmal gliomas appear to respond to irradiation with doses above 4500 rads. Patients with neurofibromatosis have about the same prognosis as patients without neurofibromatosis following irradiation of a chiasmal glioma.

Entities:  

Mesh:

Year:  1988        PMID: 3275755     DOI: 10.3171/jns.1988.68.1.0085

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  43 in total

1.  Visual pathway glioma: an erratic tumour with therapeutic dilemmas.

Authors:  A Shuper; G Horev; L Kornreich; S Michowiz; R Weitz; R Zaizov; I J Cohen
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Optic pathway glioma: outcome and prognostic factors in a surgical series.

Authors:  Yong Ahn; Byung-Kyu Cho; Seung-Ki Kim; You-Nam Chung; Chang Sub Lee; Il Han Kim; Sei Won Yang; Hee-Soo Kim; Hyun Jib Kim; Hee-Won Jung; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2006-04-21       Impact factor: 1.475

3.  Reversible endocrine dysfunction and pituitary stalk enlargement.

Authors:  A Chico; M Puig-Domingo; P Martul; M De Juan; J M Prats; D Mauricio; S M Webb
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

4.  Impact of vision loss among survivors of childhood central nervous system astroglial tumors.

Authors:  Peter M K de Blank; Michael J Fisher; Lu Lu; Wendy M Leisenring; Kirsten K Ness; Charles A Sklar; Marilyn Stovall; Chris Vukadinovich; Leslie L Robison; Gregory T Armstrong; Kevin R Krull
Journal:  Cancer       Date:  2016-01-11       Impact factor: 6.860

5.  Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type-1.

Authors:  R Listernick; J Charrow; T Tomita; S Goldman
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 6.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

Review 7.  Biological aspects of brain tumors in infancy and childhood.

Authors:  R Giuffrè
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

8.  Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: case report and literature review.

Authors:  Elpis Mantadakis; Maria Raissaki; Vassiliki Danilatou; Alexander Kambourakis; Eftichia Stiakaki; Maria Kalmanti
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

9.  Our treatment philosophy of gliomas of the anterior visual pathways.

Authors:  V Benes; I Julisová; I Julis
Journal:  Childs Nerv Syst       Date:  1990-03       Impact factor: 1.475

10.  Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children.

Authors:  Ting-Rong Hsu; Tai-Tong Wong; Feng-Chi Chang; Donald M Ho; Ren-Bin Tang; Peck-Foong Thien; Kai-Ping Chang
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.